Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2007

01-04-2007 | Original Article

Quantitative Tissue Blood Flow Measurement of the Liver Parenchyma: Comparison Between Xenon CT and Perfusion CT

Authors: Kazuhiko Hashimoto, Takamichi Murakami, Keizo Dono, Masatoshi Hori, Tonsok Kim, Masayuki Kudo, Shigeru Marubashi, Atsushi Miyamoto, Yutaka Takeda, Hiroaki Nagano, Koji Umeshita, Hironobu Nakamura, Morito Monden

Published in: Digestive Diseases and Sciences | Issue 4/2007

Login to get access

Abstract

The purpose of this study was to compare measurements of hepatic tissue blood flow (TBF) calculated by xenon and perfusion CT. Seven patients with normal liver and eight with chronic liver disease underwent both xenon and perfusion CT. During xenon CT examinations, serial abdominal CT scans were obtained every minute before and during 4 min of nonradioactive 25% (v/v) xenon gas inhalation and 5 min of administration of oxygen-rich air. Hepatic arterial and portal venous TBF were measured separately with a special imaging system using the Kety-Schmidt expression based on the Fick principle (AZ-7000W; Anzai Medical Co.). The hepatic arterial fraction (HAF) was calculated as follows: [hepatic arterial TBF/(hepatic arterial TBF + portal venous TBF)]. During perfusion CT examinations, total hepatic TBF and HAF were also calculated from the enhanced CT cine image data on a workstation using a commercially available software package based on a deconvolution algorithm (CT Perfusion 3 GE Healthcare, USA). Total hepatic TBF measured by xenon and perfusion CT was 82.9±15 and 82.8±18 ml/min/100 g, respectively. The measured values by the two techniques showed a significant correlation (R 2= 0.657, P < 0.05). HAF measured by xenon and perfusion CT was 26.6±11 and 21.8±13%, respectively. The measured values by the two techniques also showed a significant correlation (R 2= 0.869, P < 0.05). We conclude that there was a good correlation between hepatic TBF quantified by xenon CT and perfusion CT.
Literature
1.
go back to reference Leen E, Goldberg JA, Anderson JR, Robertson J, Moule B, Cook TG, Mcardle CS (1993) Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis. Gut 34:554–557PubMed Leen E, Goldberg JA, Anderson JR, Robertson J, Moule B, Cook TG, Mcardle CS (1993) Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis. Gut 34:554–557PubMed
2.
go back to reference Tsushima Y, Blomley MJ, Kusano S, Endo K (1999) The portal component of hepatic perfusion measured by dynamic CT: an indicator of hepatic parenchymal damage. Dig Dis Sci 44:1632–1638PubMedCrossRef Tsushima Y, Blomley MJ, Kusano S, Endo K (1999) The portal component of hepatic perfusion measured by dynamic CT: an indicator of hepatic parenchymal damage. Dig Dis Sci 44:1632–1638PubMedCrossRef
3.
go back to reference Lautt WW (1985) Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol 249:G549–G556PubMed Lautt WW (1985) Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol 249:G549–G556PubMed
4.
go back to reference Kleber G, Steudel N, Behrmann C, Zipprich A, Hubner G, Lotterer E, Fleig WE (1999) Hepatic arterial flow volume and reserve in patients with cirrhosis: use of intra-arterial Doppler and adenosine infusion. Gastroenterology 116:906–914PubMedCrossRef Kleber G, Steudel N, Behrmann C, Zipprich A, Hubner G, Lotterer E, Fleig WE (1999) Hepatic arterial flow volume and reserve in patients with cirrhosis: use of intra-arterial Doppler and adenosine infusion. Gastroenterology 116:906–914PubMedCrossRef
5.
go back to reference Johnson DJ, Muhlbacher F, Wilmore DW (1985) Measurement of hepatic blood flow. J Surg Res 39:470–481PubMedCrossRef Johnson DJ, Muhlbacher F, Wilmore DW (1985) Measurement of hepatic blood flow. J Surg Res 39:470–481PubMedCrossRef
6.
go back to reference Zeeh J, Lange H, Bosch J, Pohl S, Loesgen H, Eggers R, Navasa M, Chesta J, Bircher J (1988) Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Gastroenterology 95:749–759PubMed Zeeh J, Lange H, Bosch J, Pohl S, Loesgen H, Eggers R, Navasa M, Chesta J, Bircher J (1988) Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Gastroenterology 95:749–759PubMed
7.
go back to reference Miles KA, Hayball MP, Dixon AK (1993) Functional images of hepatic perfusion obtained with dynamic CT. Radiology 188:405–411PubMed Miles KA, Hayball MP, Dixon AK (1993) Functional images of hepatic perfusion obtained with dynamic CT. Radiology 188:405–411PubMed
8.
go back to reference Ziegler SI, Haberkorn U, Byrne H, Tong C, Kaja S, Richolt JA, Byrne H, Tong C, Schosser R, Krieter H, Kaja S, Richolt JA, Lammertsma AA, Price P (1996) Measurement of liver blood flow using oxygen-15 labelled water and dynamic positron emission tomography: limitations of model description. Eur J Nucl Med 23:169–177 Ziegler SI, Haberkorn U, Byrne H, Tong C, Kaja S, Richolt JA, Byrne H, Tong C, Schosser R, Krieter H, Kaja S, Richolt JA, Lammertsma AA, Price P (1996) Measurement of liver blood flow using oxygen-15 labelled water and dynamic positron emission tomography: limitations of model description. Eur J Nucl Med 23:169–177
9.
go back to reference Taourel P, Blanc P, Dauzat M, Chabre M, Pradel J, Gallix B, Larrey D, Bruel JM (1998) Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure. Hepatology 28:932–936PubMedCrossRef Taourel P, Blanc P, Dauzat M, Chabre M, Pradel J, Gallix B, Larrey D, Bruel JM (1998) Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure. Hepatology 28:932–936PubMedCrossRef
10.
11.
go back to reference Gur D, Good WF, Herbert DL, Yonas H, Wozney P, Van Thiel DH, Wolfson SK Jr (1985) Blood flow mapping in the human liver by the xenon/CT method. J Comput Assist Tomogr 9:447–450PubMedCrossRef Gur D, Good WF, Herbert DL, Yonas H, Wozney P, Van Thiel DH, Wolfson SK Jr (1985) Blood flow mapping in the human liver by the xenon/CT method. J Comput Assist Tomogr 9:447–450PubMedCrossRef
12.
go back to reference Sase S, Monden M, Oka H, Dono K, Fukuta T, Shibata I (2002) Hepatic blood flow measurements with arterial and portal blood flow mapping in human liver by means of xenon CT. J Comput Assist Tomogr 26:243–249PubMedCrossRef Sase S, Monden M, Oka H, Dono K, Fukuta T, Shibata I (2002) Hepatic blood flow measurements with arterial and portal blood flow mapping in human liver by means of xenon CT. J Comput Assist Tomogr 26:243–249PubMedCrossRef
13.
go back to reference Bader TR, Herneth AM, Blaicher W, Steininger R, Mühlbacher F, Lechner G, Grabenwoger F (1998) Hepatic perfusion after liver transplantation: noninvasive measurement with dynamic single-section CT. Radiology 209:129–134PubMed Bader TR, Herneth AM, Blaicher W, Steininger R, Mühlbacher F, Lechner G, Grabenwoger F (1998) Hepatic perfusion after liver transplantation: noninvasive measurement with dynamic single-section CT. Radiology 209:129–134PubMed
14.
go back to reference Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y (2001) Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol 176:667–673PubMed Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y (2001) Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol 176:667–673PubMed
15.
go back to reference Lee TY (2002) Functional CT: physiological models. Trends Biotechnol 20:S3–S10CrossRef Lee TY (2002) Functional CT: physiological models. Trends Biotechnol 20:S3–S10CrossRef
16.
go back to reference Blomley MJ, Lim AK, Harvey CJ, Patel N, Eckersley RJ, Basilico R, Heckemann R, Urbank A, Cosgrove DO, Taylor-Robinson SD (2003) Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: A cross sectional study. Gut 52:1188–1193PubMedCrossRef Blomley MJ, Lim AK, Harvey CJ, Patel N, Eckersley RJ, Basilico R, Heckemann R, Urbank A, Cosgrove DO, Taylor-Robinson SD (2003) Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: A cross sectional study. Gut 52:1188–1193PubMedCrossRef
17.
go back to reference World Medical Association (2000) Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 284:3043–3045CrossRef World Medical Association (2000) Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 284:3043–3045CrossRef
18.
go back to reference Kalender WA, Polacin A, Eidloth H, Kashiwagi S, Yamashita T, Nakano S (1991) Brain perfusion studies by xenon-enhanced CT using washin/washout study protocols. J Comput Assist Tomogr 15:816–822PubMedCrossRef Kalender WA, Polacin A, Eidloth H, Kashiwagi S, Yamashita T, Nakano S (1991) Brain perfusion studies by xenon-enhanced CT using washin/washout study protocols. J Comput Assist Tomogr 15:816–822PubMedCrossRef
19.
go back to reference Kety S (1951) The theory and applications of the exchange of inert gas at the lungs and tissue. Pharmacol Rev 3:1–41PubMed Kety S (1951) The theory and applications of the exchange of inert gas at the lungs and tissue. Pharmacol Rev 3:1–41PubMed
20.
go back to reference Fick A (1870) Uber die Messung des Blutquantums in den Herzventrikeln Verhandl dphys-med Ges zu Wurzburg 2:16–28 Fick A (1870) Uber die Messung des Blutquantums in den Herzventrikeln Verhandl dphys-med Ges zu Wurzburg 2:16–28
21.
go back to reference Sase S (1996) Correction method for end-tidal xenon concentration in CBF measurements with xenon-enhanced CT. J Comput Assist Tomogr 20:688–692PubMedCrossRef Sase S (1996) Correction method for end-tidal xenon concentration in CBF measurements with xenon-enhanced CT. J Comput Assist Tomogr 20:688–692PubMedCrossRef
22.
go back to reference Meyer JS, Hayman LA, Yamamoto M, Sakai F, Nakajima S (1980) Local cerebral blood flow measured by CT after stable xenon inhalation. AJR Am J Roentgenol 135:239–251PubMed Meyer JS, Hayman LA, Yamamoto M, Sakai F, Nakajima S (1980) Local cerebral blood flow measured by CT after stable xenon inhalation. AJR Am J Roentgenol 135:239–251PubMed
23.
go back to reference Frackowiak RS, Lenzi GL, Jones T, Heather JD (1980) Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr 4:727–736PubMedCrossRef Frackowiak RS, Lenzi GL, Jones T, Heather JD (1980) Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr 4:727–736PubMedCrossRef
24.
go back to reference Brasch RC, Weinmann HJ, Wesbey GE (1984) Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex. AJR Am J Roentgenol 142:625–630PubMed Brasch RC, Weinmann HJ, Wesbey GE (1984) Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex. AJR Am J Roentgenol 142:625–630PubMed
25.
go back to reference Winkler SS, Holden JE, Sackett JF, Flemming DC, Alexander SC (1977) Xenon and krypton as radiographic inhalation contrast media with computerized tomography: preliminary note. Invest Radiol 12:19–20PubMedCrossRef Winkler SS, Holden JE, Sackett JF, Flemming DC, Alexander SC (1977) Xenon and krypton as radiographic inhalation contrast media with computerized tomography: preliminary note. Invest Radiol 12:19–20PubMedCrossRef
26.
go back to reference Miles KA (1991) Measurement of tissue perfusion by dynamic computed tomography. Br J Radiol 64:409–412PubMedCrossRef Miles KA (1991) Measurement of tissue perfusion by dynamic computed tomography. Br J Radiol 64:409–412PubMedCrossRef
27.
go back to reference Latchaw RE, Yonas H, Pentheny SL, Gur D (1987) Adverse reactions to xenon-enhanced CT cerebral blood flow determination. Radiology 163:251–254PubMed Latchaw RE, Yonas H, Pentheny SL, Gur D (1987) Adverse reactions to xenon-enhanced CT cerebral blood flow determination. Radiology 163:251–254PubMed
28.
go back to reference Okumura M, Toyoshima N, Katada K, Sasaki M (2003) Performance evolution for image filters used for CT images. Radiological Society of North America. 89th Scientific assembly and annual meeting program: 720 Okumura M, Toyoshima N, Katada K, Sasaki M (2003) Performance evolution for image filters used for CT images. Radiological Society of North America. 89th Scientific assembly and annual meeting program: 720
Metadata
Title
Quantitative Tissue Blood Flow Measurement of the Liver Parenchyma: Comparison Between Xenon CT and Perfusion CT
Authors
Kazuhiko Hashimoto
Takamichi Murakami
Keizo Dono
Masatoshi Hori
Tonsok Kim
Masayuki Kudo
Shigeru Marubashi
Atsushi Miyamoto
Yutaka Takeda
Hiroaki Nagano
Koji Umeshita
Hironobu Nakamura
Morito Monden
Publication date
01-04-2007
Published in
Digestive Diseases and Sciences / Issue 4/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9327-6

Other articles of this Issue 4/2007

Digestive Diseases and Sciences 4/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine